Armata Pharmaceuticals (ARMP) Profit After Tax: 2013-2024
Historic Profit After Tax for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$18.9 million.
- Armata Pharmaceuticals' Profit After Tax rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 23.75%. This contributed to the annual value of -$18.9 million for FY2024, which is 72.60% up from last year.
- As of FY2024, Armata Pharmaceuticals' Profit After Tax stood at -$18.9 million, which was up 72.60% from -$69.0 million recorded in FY2023.
- Armata Pharmaceuticals' Profit After Tax's 5-year high stood at -$18.9 million during FY2024, with a 5-year trough of -$69.0 million in FY2023.
- Over the past 3 years, Armata Pharmaceuticals' median Profit After Tax value was -$36.9 million (recorded in 2022), while the average stood at -$41.6 million.
- Per our database at Business Quant, Armata Pharmaceuticals' Profit After Tax plummeted by 87.03% in 2023 and then soared by 72.60% in 2024.
- Armata Pharmaceuticals' Profit After Tax (Yearly) stood at -$22.2 million in 2020, then decreased by 4.39% to -$23.2 million in 2021, then plummeted by 59.43% to -$36.9 million in 2022, then plummeted by 87.03% to -$69.0 million in 2023, then surged by 72.60% to -$18.9 million in 2024.